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Biomechanics of soft tissue 
A B S T R A C T   
Intestinal tissue, and specifically its mucosal layer, is a complex and gradient-rich environment. Gradients of 
soluble factor (BMP, Noggin, Notch, Hedgehog, and Wnt), insoluble extracellular matrix proteins (laminins, 
collagens, fibronectin, and their cognate receptors), stromal stiffness, oxygenation, and sheer stress induced by 
luminal fluid flow at the crypt-villus axis controls and supports healthy intestinal tissue homeostasis. However, 
due to current technological challenges, very few of these features have so far been included in in vitro intestinal 
tissue mimetic platforms. In this review, the tightly defined and dynamic microenvironment of the intestinal 
tissue is presented in detail. Additionally, the authors introduce the current state-of-the-art intestinal tissue 
mimetic platforms, as well as the design drawbacks and challenges they face while attempting to capture the 
complexity of the intestinal tissue’s physiology. Finally, the compositions of an “idealized” mimetic system is 
presented to guide future developmental efforts.   
1. Introduction 
The small intestine (SI), the location of the majority of nutrient ab-
sorption. It is composed of four layers, each with a distinct function and 
anatomy: serosa, muscularis externa, submucosa, and mucosa [1]. The 
functions of the mucosal epithelium include digestion and nutrient ab-
sorption, the formation of a protective barrier, and the secretion of 
mucous and hormones [1]. The mucosal layer, which harbors the 
epithelium, is covered in adjoining villi and crypt units (Fig. 1), and in 
order to maintain its integrity, it is fully renewed every 4–5 days [2]. 
Each villus-crypt unit can be divided into three distinct zones; the crypt, 
the transient amplifying (TA) zone, and the villus as seen in Fig. 1. 
Located at the base of the intestinal crypt are the antimicrobial 
peptide-secreting Paneth cells [3]. The main function of Paneth cells is 
to produce, package and export inflammatory cytokines and various 
antimicrobial peptides and proteins [4]. Thus Paneth cells are hypoth-
esized to regulate intestinal microbiome composition and pathogen 
clearance [5]. Beyond their antimicrobial activity, Paneth cells can 
regulate the replication dynamics of intestinal stem cells (ISCs). Under 
calorie restriction, they downregulate their mammalian target of rapa-
mycin complex 1 (mTORC1) production and in doing so, the release of 
various signaling molecules including bone stromal antigen 1 (Bst-1), an 
ectoenzyme that produces the paracrine factor cyclic ADP ribose 
(cADPR), is triggered. cADPR produced by Paneth cells, is responsible 
for signaling their neighboring ISCs to self-renew instead of differentiate 
[6,7]. 
ISCs are reservoir cells with a high level of regenerative capacity. 
Through their ability to divide asymmetrically, they can give rise to two 
daughter cells, one which retains its ISC stem-like properties, and 
another one, that possesses the ability to differentiate into non-stem cells 
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of different fates. ISCs divide infrequently and then return to dormancy 
(G0/quiescence) once the requirement for new cells is fulfilled. This 
ability to jump between active proliferation and quiescence is tightly 
controlled and is the keystone of healthy tissue regeneration. Recently, a 
second subpopulation of largely dormant ISCs was identified based on 
their ability to retain a replication sensitive dye-like bromodeoxyuridine 
(BRDU) over a long time and, accordingly, have been classified as long- 
term label-retaining cells (LRCs) [8]. It has been postulated that LRCs 
play a critical role in long-term tissue homeostasis, serving as the pri-
mary reservoir of high-fidelity genetic information [8,9]. This extremely 
slow-replicating sub-population of deeply quiescent ISCs, is believed to 
only be active during development and under moments of extreme 
duress, such as during the process of wound healing in various tissues [9, 
10]. 
After ISC proliferation, ISC progenitors replicate rapidly as they 
move upwards through the TA zone, before terminally differentiating 
into a single layer of epithelial cells that line the villus ultrastructure 
[11]. Four types of matured epithelial cells can be found here; enter-
ocytes, which absorb nutrients [12], goblet cells, which secrete a pro-
tective mucous barrier [13], enteroendocrine cells which produce 
gastrointestinal hormones, and microfold (M) cells, which cover the 
lymphoid associated Peyer’s patches [14]. These M cells continuously 
sample luminal antigens form the underlying lymphoid follicles to 
trigger immune responses [14]. 
Intestinal tissue homeostasis is heavily controlled by the cells’ 
changing microenvironment, also called the niche. As the intestinal cells 
move through the crypt-villus axis, they interact with their local sur-
roundings, which regulate their stemness, proliferative state and their 
commitment to certain cell lineages. The spatial change in niche 
composition can be categorized in terms of soluble molecule gradients 
(growth factors, hormones, and signaling molecules), insoluble mole-
cule gradients (extracellular matrix components), and the mechanical 
features of the tissue (Fig. 2). In order to understand intestinal cell 
behavior, many intestinal tissue features have been recapitulated in 
vitro. Due to the extremely complex intestinal tissue composition and 
current technological shortfalls, this organ has not yet been successfully 
mimicked to a satisfactory level. The authors assert that the various 
gradients present in this tissue are vital to its overall architecture and 
function, and understanding them may help in addressing this shortfall. 
This review discusses the currently known gradients of oxygen, 
extracellular matrix (ECM), soluble factors, mechanical forces, and 
matrix stiffness in the dynamic intestinal niche, which maintains the 
Fig. 1. The intestinal tube has four distinct layers; serosa, muscularis, submucosa and mucosa. Mucosal layer of the small intestine is covered with small finger like 
projections, called villi, with spaces between two adjacent villi termed the crypt. Crypts hold intestinal Paneth and stem cells, where the latter through proliferation 
are able to give rise to intestinal epithelial cell types such as; enterocytes, microfold, goblet, enteroendocrine and tuft cells. Underlying the intestinal epithelium is the 
stroma or lamina propria, which is composed of a network of spatially distributed extracellular matrix proteins and is a home for various immune cell types, fi-
broblasts, and muscle cells. 
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balance between quiescence, proliferation, and differentiation. The re-
view also examines requirements for the “idealized” intestinal model, 
and how these are currently addressed in state-of-the-art intestinal 
models. 
2. Biochemical, biomechanical, gas, and microbiome gradients 
in the ISC niche 
2.1. Soluble factors 
In the intestine, a multitude of soluble factor gradients span across 
the crypt-villus axis. Gradients of Wnt [15,16], Noggin [16], epidermal 
growth factor (EGF) [17], and Notch [17] decrease, moving from crypt 
to villus, while bone morphogenetic protein (BMP) [16,17] and ephrin-B 
[17] increase (Fig. 2). 
2.1.1. Wnt/β-catenin role in ISC maintenance 
The Wnt/β-catenin signaling pathway determines developmental 
processes and contributes to the proliferation and maintenance of ISCs 
in the gut [18–21]. Wnt ligand such as Wnt3, Wnt6, and Wnt9b 
expression and their cognate receptor saturation is greatest at the crypt 
base, gradually dissipating towards the villus. Similarly, nuclear β-cat-
enin levels decrease from the base of the crypt to the villus region [18]. 
Paneth cells produce Wnts, which bind to ISCs through their 
highly-expressed FZD membrane receptors. Regulation of FZD Wnt re-
ceptor, membrane-bound Wnt concentration at the crypt bottom is 
gradually reduced, providing a gradient of Wnts along the crypt-villus 
unit. 
2.1.2. BMP regulates crypt formation and terminal differentiation 
In the gut, BMPs are secreted by epithelium-underlying stromal cells, 
such as myofibroblasts. BMP gradients, predominantly BMP2 and -4, are 
found in an inverse orientation to Wnt ligand gradients along the villus- 
crypt axis (Fig. 2), and coincide with reduced proliferation and 
increased differentiation when the cells move from low BMP to higher 
levels at the crypt-villus transition [22–24]. The BMP pathway is 
required for the modulation of negative crypt formation. Additionally, it 
supports terminal progenitor cell differentiation into mature intestinal 
cell-type lineages. In the ISC compartment, BMP signaling is modulated 
by the underlying mesenchyme-secreted BMP antagonists gremlin-1/-2, 
chordin, Noggin, and angiopoietin-related protein 2 (ANGPTL2). BMP 
signaling is required for the maintenance of tissue homeostasis [25] and 
in the intestine, its deficiency is associated with abnormal villus devel-
opment, epithelial hyperplasia, and ectopic crypt formation [26]. 
2.1.3. Ephrin signaling modulates correct cell positioning along crypt-villus 
axis 
Ephrin-B1 concertation gradient at the crypt-villus axis gradient has 
been shown to control the positioning and migration of intestinal 
epithelial cells [27]. Elevated levels of Wnt signaling at the bottom of the 
crypts simultaneously induce expression of ephrinB2, ephrinB3, and the 
transcriptional repression of their repulsive ephrin-B1 ligand [28]. ISCs 
have shown elevated levels of EphB2 expressions, while Paneth cells are 
negative for EphB2 but produce EphB3 [28,29]. The reduction of Wnt 
soluble factor concentration gradient along the crypt-villus interface 
results in activation of repulsive ephrin-B1 ligand. Simultaneously, 
EphB2 expression reduces in TA cells as they migrate upwards through 
the crypt-villus axis. The gradients of repulsive Eph2 and -3 and 
ephrin-B1 interaction facilitates correct cell location through the 
crypt-villus axis, where differentiated cells are constantly travelling to-
wards the villus top. Interestingly, as Paneth cells highly express the 
EphB3, therefore missing the upwards cell migration, remaining at 
lower part of the crypt [28,30,31]. 
2.1.4. Epithelial hedgehog signals patterns the gut 
Hedgehog signaling has been identified as key regulator of the gut 
mesenchymal compartment development and homeostasis [32]. There 
are three hedgehog paralogues in mammals: Indian (IH), Sonic (SH), and 
Desert (DH), where SH is expressed at the base of the small intestinal and 
colonic crypts [33,34]. Hedgehog ligands are produced by intestinal 
epithelial cells and act directly on Hedgehog receptors; Patched 1 and 
Patched 2, expressed on the mesenchymal cells, thus activating pro-
duction of BMPs [34,35], binding to their receptors expressed by 
epithelial cells counteracting the Wnt pathway. Furthermore, the acti-
vation of hedgehog signaling by either deletion of PTCH or over-
expression of IH in mouse intestinal epithelium leads to the 
accumulation of mesenchymal cells. The loss of hedgehog signaling in 
the adult intestine showed that it is essential for the development of the 
Fig. 2. Gradients of; soluble factor, underlying ECM protein network, O2, stromal stiffness at the villus-crypt axis, which all together are responsible for controlling 
the correct heathy gut homeostasis. 
S. Malijauskaite et al.                                                                                                                                                                                                                          
Cytokine and Growth Factor Reviews 60 (2021) 76–88
79
mesenchyme and maintenance of villus structure, as well as the main-
tenance of the smooth muscle cells and myofibroblasts [36]. Addition-
ally, its absence allowed enhanced Wnt signaling, thus reducing 
differentiation and resulting in shortened crypts with blunted villi. 
Therefore, hedgehog signaling exhibits an indirect modulation of ISCs 
by induction of suppressive BMP signaling and the regulation of un-
derlying stromal compartments that provide a supportive scaffolding for 
intestinal epithelium. 
2.1.5. Notch regulates ISC renewal and differentiation 
Notch signaling has been shown to regulates ISC renewal and TA cell- 
fate decision in conjunction with Wnt signaling, which works as the 
promoter of cell proliferation and suppressor of differentiation [2,8, 
37–39]. When Notch signaling is completely suppressed through double 
knock-out of Notch1/Notch2 receptors, ISC proliferation is reduced and 
they differentiate into secretory goblet cells at the expense of absorptive 
enterocytes [40,41]. This implies that Notch signaling controls the 
regulation of ISC fate decision between secretory or absorptive lineages. 
In a complementary experiment, elevated expression resulted in the 
reduction of secretory cells and elevated cell proliferation [42]. 
Together, these results identify Notch either as a proliferation promoter 
in ISCs and TA cell compartments, or as a regulator of cell lineage de-
cision between absorptive or secretory cells. 
Together, the aforementioned soluble factors and their ligand 
spatiotemporal distribution warrant the activation or inhibition of key 
signaling pathways, which are the cornerstone of gut homeostasis. 
2.2. Insoluble factors 
Alongside soluble factor gradients, there also exits an insoluble fac-
tor gradient around the crypt-villus axis. These include the ECM proteins 
and their receptors, which support intestinal tissue turnover (Fig. 2). 
2.2.1. Collagens 
Collagen is the most abundant protein found in the human body, and 
the most prominent subtypes found in the intestine include types I, III, 
IV, and VI [43]. Collagen type VI has been identified as a modulator of 
the niche microenvironment in the ISC compartment through amino 
acid Arg-Gly-Asp receptor interactions [44,45]. Cells found at the in-
testinal crypts have been known to express collagen VI on to the sur-
rounding basal membrane. Heavier deposition of collagen influences 
surrounding tissue stiffness, rendering it tougher, and this, in turn has an 
effect on focal adhesions and cytoskeletal mediated cell contractility 
[46]. 
2.2.2. Laminins 
Laminins are tripeptides with α, β, and γ domains and are the major 
components of the basal lamina (BM), which is the 3D underlying mesh 
network that is the foundation of most tissues. Specifically, α domains 
have been identified as primary regulators of epithelial cell polarity, 
Fig. 3. A-Laminin distribution in the intestinal crypt-villus [56] (reproduced with permission), B-Laminins and their binding integrins present on the cell surface, 
binding affinities are separated into high, medium, and low, C-integrin mediated inside-out and outside-in signaling. 
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proliferation, differentiation, and survival [47–51]. Thus far, the spatial 
knowledge of laminin deposition at the crypt-villus unit identifies that 
laminins α1 and α2 are highly deposited at the crypt base while laminins 
α3 and α5 have been shown to localize at the differentiated villus region 
[50,52]. 
Laminin α5 has been identified as a critical constituent for the 
maintenance of the mucosal patterning by controlling the villus archi-
tecture [53,54]. A recent study on neural stem cell (NSC) niche prote-
omics has shown enrichment profiles for α1, α2, α3, α4, and α5 in the 
brain matrisome [55]. Overall findings argue that laminin α subunits 
have a spatial distribution in different organs, and that each of them 
plays a specific role in specific tissue maintenance and regeneration. 
Therefore, laminin protein spatial localization in tissues, such as the 
intestine, should be further investigated and used to the advantage of 
tissue-specific scaffold designs, potentially leading to tissue architecture 
for regenerative medicine applications (Fig. 3A) [56]. 
2.2.3. Fibronectin 
Fibronectin (FN) is another large glycoprotein that is widely 
distributed in the ECM, playing a role in facilitating cell adhesion, 
migration, and differentiation. FN has a multifunctional structural role 
in the ECM as it is able to bind to other ECM proteins, like collagens [57]. 
In the intestine, FN is expressed into the underlying basement membrane 
by intestinal fibroblast and epithelial cells [58–60], where inflammatory 
bowel disease (IBS) and colitis have been known to have elevated FN 
depositions [57]. 
2.2.4. Laminin cognate receptor-integrin regulated tissue architecture 
Laminin-binding integrins are critical in the modulation of stem cell 
niche dynamics. Previous knock-out studies uncovered that deletion of 
integrin α1 or α2 does not have any discernable defects, however, 
deletion of integrins α3, α6, α7, or β6 caused severe defects in tissue 
development and homeostasis [61,62]. Therefore, integrins α1β1, α2β1, 
α3β1, α6β1, α6β4, and α7β1 have been identified as broad 
laminin-binding integrins, while α3β1, α6β1, α6β4, and α7β1 are known 
as the major laminin-binding integrins (Fig. 3B). 
Former studies have identified that integrins α3β1, α6β1, and α6β4 
display preferential binding for laminin α5 (laminin 511/521) and α3 
(laminin 332), where two spliced isoforms of α7β1: α7 × 1β1 and α7 ×
2β1 have preferential binding to all laminins except α3 or α1, α2, and α5, 
respectively [63]. α7 × 1β1 and α7 × 2β1 are the only integrins to 
display a high biding affinity to major muscle cell basement membrane 
laminin α2. Furthermore, the importance of laminin protein in heathy 
tissue homeostasis has been explored in knock-out mice studies of α3, 
β2, and γ2 chains which have led to a manifestation of a severe form of 
blistering disease, known as Epidermolysis bullosa, similarly seen in 
integrins α6- or β4- deficient mice, the laminin 322 binding integrin 
group [64–68]. Moreover, the intestinal villus-crypt unit basement 
membrane has a clear special segregation of laminin proteins and their 
cognate receptors-integrins (Fig. 3A) [56]. For example, laminins α1 and 
α2 have been identified as intestinal crypt-based ECM constituents, 
while laminins α3 and α5, and their corresponding binding integrin 
α3β1, localize at the villus region [50,56,69]. Many studies have 
recognized integrins and laminins as important regulators of healthy 
tissue homeostasis, and their distinct spatial gradient, as seen in the 
intestinal crypt-villus axis, suggests an even greater and precisely 
defined function in gut epithelium regeneration. Recent findings suggest 
that specific laminins are the major regulators of epidermal stem cell and 
progenitor cell numbers, which have been known to exponentially 
decrease during aging [70]. 
2.3. O2 gradient 
In-depth studies of the intestinal mucosa have provided valuable 
insights into metabolic requirements associated with normal tissue 
function, which depends on the O2 availability. Gut tissue is character-
ized by a unique oxygenation profile, exhibiting highly varied O2 satu-
rations at the crypt-villus coupled with temporal fluctuations 
throughout the day [71,72]. Under standard conditions, intestinal 
epithelial cells exist in a low O2 environment, which could be described 
as physiological hypoxia. The O2 exchange mechanism in the SI has 
shown that O2 from arterial blood diffuses to juxtapose venules across 
the crypt-villus unit [73], producing a low O2 gradient of 80− 100 mm 
Hg at the crypt and diffusing to <10 mm Hg at the villus tip. The O2 
distribution between the crypt and intestinal lumen also influence 
anaerobic microbiome population density along the crypt-villus unit 
[74–76]. Additionally, intestinal microbes have been known to produce 
many gasses such as methane, H2, and H2S, which can also be gradually 
distributed along the crypt-villus axis and have an impact on the intes-
tinal epithelium [77–79]. 
2.4. Microbiome 
One of the most important functions of the intestinal epithelium is to 
provide a physical barrier between the gut microbiome and the rest of 
the body. During evolution, the symbiotic relationship between a human 
and its intestinal microbiome has led to intestinal epithelial cells 
developing many mechanisms to sense and respond to the activity of 
microbiota, highlighting the importance of microbial products when 
documenting gradients across the epithelium [80,81]. 
Fig. 4. Different tissue stiffness: A-range of stiffnesses of different tissues and substrates, B-effects of stiff versus soft matrices on cell morphology, C-stiffness gradients 
and their effects on cell behavior. 
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Intestinal epithelial cells present pattern recognition receptors 
(PRRs) on their cell membrane, which allow for the detection of mo-
lecular signaling arising from the pathogenic or commensal microbiome 
[82–84], followed by the production of antimicrobial peptides, mucous, 
tight junction strengthening, epithelial cell proliferation, differentiation, 
and immune response [85]. For example, microbiome assisted fermen-
tation of dietary components produce metabolites, such as tryptophan 
catabolites (TC)s. TCs detected by pregnane X receptors (PXRs) and aryl 
hydrocarbon receptors (AHRs) take part in anti-inflammatory and bar-
rier formation functions [86–88]. Through AHR sensing of either tryp-
tophan or other dietary components, intestinal barrier formation is 
strengthened by induced ISC proliferation and terminal differentiation, 
which facilitates inflammatory response mitigation [88]. 
2.5. Biomechanical gradients 
A number of biomechanical gradients exist in the villus-crypt unit. 
These are necessary for the development and proliferation of the native 
cells and include the stiffness gradient, as well as apical fluidic forces 
acting on the cells due to contained intestinal fluids and movement. 
2.5.1. Stiffness gradient 
Scientific evidence has long supported the hypothesis that the me-
chanical properties of biological tissues are essential for cellular 
behavior and adequate tissue function [89] with stiffnesses, varying 
from 11 Pa in intestinal mucous to 20 GPa in cortical bone [90,91] 
(Fig. 4A). Furthermore, mechanical signals arising from the niche 
microenvironment determine ISC fate though regulation of prolifera-
tion, differentiation, apoptosis, and migration [92–94]. Currently, there 
are many examples of the mechanical characterization of tissues at bulk 
level, but little or no characterization at macro or nano-scales, including 
the tissue stiffness gradient at the basement membrane of the intestinal 
crypt-villus unit. However, different amounts of collagen in submucosa 
and mucosa of the large intestine of rats (80 % and 30 % respectively 
[95]) have led to the assumption that there is a stiffness gradient be-
tween intestinal tissue layers. Therefore, it is reasonable to assume that a 
stiffness gradient exists at the crypt-villus interface, particularly as 
previous studies have identified that ISCs proliferate on stiff matrices 
and differentiate on softer ones. 
2.5.2. Apical fluid mechanics and forces 
At its most simplistic level, the flow of digestive fluids in the in-
testines can be approximated as fully developed Poiseuille flow [96]. In 
this flow regime, endothelial cells experience different types of me-
chanical forces; wall shear stress, hydrostatic pressure, and forces 
arising from cell-cell adhesions [97,98], illustrated in Fig. 5. Hydrostatic 
pressure, in blue, arising from the fluid in the tract, acts perpendicularly 
to the walls. Its value varies, depending on the volume of fluid in the 
tract, with previous studies showing that an increase leads to added 
absorption of nutrients [99,100]. Wall shear stress, illustrated in green, 
arises from a parabolic flow profile, resulting in higher shearing forces at 
the wall. This value has been estimated to be in the region of 0.2–8 mPa 
[101,102]. However, the non-uniform walls of the intestine result in an 
altered shear stress profile. Previous computational fluid dynamics 
(CFD) studies have found that shear forces follow a gradient along the 
length of each villi with low forces in the crypt, increasing towards the 
villus tips [103]. This implies that ISCs are effectively sheltered from any 
shear stress applied by the fluid, however, it is likely that it still indi-
rectly affects their function, because high wall shear stress at the villus 
tips may cause sloughing of terminally differentiated cells into the 
lumen [103]. Finally, cell-cell interactions, illustrated in Fig. 5 in yellow, 
similar to those in the vascular system (though at a lower magnitude) 
[97,98], are caused by expansion and contraction of the intestines with 
the passage of digestive fluids as well as peristaltic motion. 
While Poiseuille flow is an approximation, it fails to fully encapsulate 
the complex fluid dynamics in this environment and more sophisticated 
models may be appropriate [96] as intestinal cells may experience other 
forces not captured by these assumptions. For example, the digestive 
tract is flexible and collapsible, therefore cells at the wall come into 
contact with cells of the opposing wall, exerting further shearing forces 
on each other [104]. Additionally, fluid flow can be highly changeable, 
dominated by periods of fasting and eating, therefore, changing the 
forces that cells are subject to significantly over several hours [103]. 
Despite the large variability in these mechanical forces, these stimuli 
are necessary for the normal functioning of the cells. Actin-rich micro-
villi, lining the neonatal unilaminar epithelium, sense the shear stresses 
generated by fluid flow, causing them to develop the distinctive apical 
brush border [105]. Additionally, biomechanical cues, stimulated by 
biomechanical differences between Paneth cells and ISCs, cause crypt 
fission in healthy adult mucosa [106]. 
In summary, the multitude of biochemical (soluble and insoluble) 
and mechanical gradients along the crypt-villus interface comprise the 
ISC niche, and regulate it. Though each of these factors have been 
extensively examined in preceding studies, few of latest in vitro devices 
incorporate a number of the aspects necessary for a satisfactory dupli-
cation of the in vivo environment. 
3. Current state of the art 
Thus far tremendous effort to replicate intestinal environment has 
been documented in the literature. These efforts are comprised of in-
testinal organoid, 2D model, and organ-on-a-chip approaches. In the 
following sub-sections, we consider each in turn, describing the state-of- 
the-art and the limitations associated with each approach. 
3.1. Intestinal organoids 
Organoids are 3D micro-tissues derived from a single isolated adult 
stem cell (ASC) or an induced pluripotent stem cell (iPSC) which can 
self-organize into 3D anaerobic core constructs with organ-specific cell 
Fig. 5. Illustration of how mechanical forces, including hydrostatic pressure, shear stress and cell-cell interactions act on the endothelial cells of the small intestine.  
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types, more closely mimicking the native tissue physiology. Recent in-
testinal organoid models have allowed for long-term 3D culturing of 
intestinal epithelium which, unlike 2D models, can retain some micro-
environmental cues and better reflect original tissue physiology [107, 
108]. Intestinal organoids have been used to study new and existing 
cancer therapeutic efficacy for personalized remedy development [106, 
109] as well as that of IBS [110] and due to their anaerobic core, un-
derstand infection and various non-pathogenic host-microbe in-
teractions [111,112]. Detailed experimental procedure of organoid 
generation and applications are demonstrated in Fig. 6A. 
In native intestinal tissue, mature epithelial cells are sloughed into 
the lumen of the intestine. Contrastingly, intestinal organoids accumu-
late cellular debris in the closed-off luminal space, which are only 
removed during passaging. 
Organoids possess unnatural culture conditions, generally carried 
out on a 3D matrix Matrigel™, which is derived from a gelatinous 
extracellular matrix protein mixture found in mouse Engelbrecht-Holm- 
Swarm sarcoma cells, with its major constituent identified as laminin 
[113]. This subjects human-derived organoids to unnatural niche con-
ditions and unaccounted variables, influencing the experimental 
outcome. Additionally, organoids are cultured with expensive, 
fetal-bovine-serum-containing, niche factor-supplemented media. 
Previously, the closed-off nature of the organoid epithelium limited 
the study of apical transporters, metabolic enzymes, and microbiota 
interaction. These challenges were partially overcome by using micro-
injection or intestinal epithelium grown in 2D, however both ap-
proaches are labor intensive, require specialist equipment, and are 
relatively costly. Nonetheless, that still does not allow for the defined 
soluble factor gradient at the crypt-villus interface discussed previously, 
which is also absent in Matrigel™embedded organoids. A recent pub-
lication by Co et al., describe a method to reverse human enteroid po-
larity, thus enabling access to the apical epithelium [114]. Upon 
removing ECM scaffold proteins, basal-out enteroids evert to apical-out 
polarity in a β1 integrin-dependent manner, which allows for this model 
to be used for evaluating barrier integrity, monitoring nutrient uptake, 
and examining bacterial infection [114]. 
Contrary to the normal environment of native tissue, organoids are 
cultured under static conditions. The in vivo intestinal epithelium ex-
periences cyclical deformation during peristalsis every 7− 20 min, 
exerting a 20 mmHg pressure on the intestinal mucosa [115–117], and 
studies identified that macroscopic and microscopic forces acting on the 
gut epithelium regulate cell proliferation and differentiation [118,119]. 
Fig. 6. Organoid models and comparison to in vivo: A- iPSC or ASC derived organoids generation conditions and organoid applications (adapted from Sigma-Aldrich), 
B-Intestinal organoid topological differences to the native tissue. 
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3.2. 2D models and their limitations 
Limitations described in the preceding section outlined shortfalls 
associated with intestinal organoids and their capacity to mimic native 
intestinal tissue. Therefore, for specific applications, the scientific 
community sometimes returns to 2D cultures. These models often use 
cancer-derived cell lines such as CaCo2, HCT-116, HT-29, and SW480, 
however, they are limited to producing homogenous cell populations 
which oppose the heterogeneous intestinal epithelium. To overcome 
this, recent studies have developed methods for culturing 2D mono-
layers of disaggregated matured organoids on Matrigel™coated Trans-
wells [120–123]. 
Organoid derived monolayers, used to understand the relationship 
between the intestinal epithelium and stromal cells, found that macro-
phages showed a contribution to higher epithelial packing and increased 
photogenic activity, without initiating an inflammatory cascade in 
response to pathogen invasion [124]. Whereas, a primary co-culture of 
intestinal organoids and myofibroblasts showed myofibroblasts can be 
responsible for ISC maintenance, modulating niche factor production 
[124]. Even though 2D co-culture models allow access to the apical side 
of the intestinal epithelium, it still fails to mimic the crypt-villus 3D 
architecture, soluble and insoluble factor gradients, and any mechanical 
cues seen in the native tissue. 
3.3. Organ-on-chip devices and their limitations 
An interesting prospect developed in recent years is the emergence of 
complex bio-microfluidics systems, the so-called “organ-on-a-chip” 
technology. In these, a 2D or 3D epithelium is cultured on deformable 
semi-permeable membranes, separating the apical and basolateral 
microfluidic channel chambers (Fig. 7B), allowing for soluble molecule 
transfer. Continuous perfusion of either chambers or, deformable 
membranes, which permit mimicking of organ contractions by adja-
cently situated vacuum chambers, are advantageous during microbiome 
co-culture interaction investigations, and prevent issues of overgrowth 
associated with static culture [125–129]. Notably, shear stress was 
identified as a requirement for the development of crypt-villus archi-
tecture in organ-on-a-chip devices [101,105,130–132], as well as 
causing tight junction formation between cells, closer to physiological 
conditions than static culture [103]. Indeed, it has been shown that an 
absence or cessation of shear stress on these cells can result in involution 
[133]. Two recent studies developed innovative intestinal organ-chip 
models that identified the requirement for continuous perfusion and 
cyclic strain in order to develop a functional intestinal epithelium [134, 
135]. From these studies, the co-culture of HIMEC and disaggregated 
organoid chip models more closely recapitulated the morphology and 
multicellular composition of native intestinal tissue, however the gross 
morphology and distribution of the crypt-villus structure was disor-
dered. This was due to the absence of a suitable 3D support system, 
highlighting a requirement for the incorporation of structurally sup-
portive scaffolds that maintain proper lineage development [134,135]. 
While organ-chip devices can recapitulate certain physiological pa-
rameters and many cellular phenotypes of the intestine, they are still 
only incorporating some components of the four-layered intestinal wall, 
and thus, missing features, which play an essential role in healthy gut 
tissue. Even though polydimethylsiloxane (PDMS) is the preferred ma-
terial for manufacturing of microfluidic channels, it has the disadvan-
tage of absorbing small hydrophobic molecules on its surface [136,137]. 
Lastly, the dynamic and spatially unique basement membrane compo-
sition at the intestinal villus-crypt unit has not yet been mimicked. 
Instead, Collagen I and/or Matrigel™are used to coat the 
semi-permeable membrane. This is not the optimal method of 
mimicking the intestinal microenvironment seen in vivo, especially when 
considering the gross morphology, regularity of villus distribution and 
uniformity of the crypt-villus axis’s cell lineage behavior. 
4. Idealized intestinal model requirements 
In vitro models strive to mimic the fundamental characteristics of 
natural tissue. Therefore, a summary of these important characteristics, 
Fig. 7. Current 2D and Organ-chip models: A- 2D model configurations, from simple single cell line monolayer to complex co-cultures or 3D scaffolds mimicking 
crypt-villus topology, B-organ-chip microfluidics model of a co-culture perfused apical and basolateral chambers. 
Table 1 
Summary of idealized intestinal scaffold requirements.  
Requirement Purpose 
Flow at the apical and basolateral 
sides of the epithelium and 
peristalsis 
Regulation of cell proliferation, 
differentiation, tight junction formation, 
nutrient administration and cellular debris 
clearing. 
3D villus scaffold with zonal 
distribution of ECM 
Controlled and correct lineage maintenance 
and development. 
Gaseous gradient of O2 To support the dynamic gut colonizing 
microbiome and epithelial function. 
Soluble factor gradient For the control of correct tissue homeostasis 
and cell lineage development. 
Niche cells Endothelial cells, myofibroblasts, fibroblasts, 
muscle cells, neural cells and immune cells 
play a role in expression of some soluble and 
insoluble factors, as well as, modulation of 
inflammatory cascades.  
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which are irreplaceable in future mimetic models are included below 
(Table 1). 
The idealized intestinal model should allow for adequate perfusion at 
the apical and basolateral chambers, which represent the mucosal 
epithelium and underlying stroma, respectively (Fig. 8). Basolateral 
flow, necessary for the normal functioning of intestinal epithelial cells 
[133], is also required to duplicate the native oxygen-rich microenvi-
ronment of circulating immune cells which come into contact with the 
epithelium in vivo. Additionally, oxygen-low fluid flow at the apical 
chamber would allow for nutrient administration, cellular debris 
clearing, and would provide a physiologically relevant sheer stress. 
Previous studies have shown that circulating cells react differently to the 
same cells under static conditions [138,139], implying that the incor-
poration of circulating immune cells into a gut-on-a-chip device is a 
necessary requirement. While some models have incorporated either 
flow, cell-cell stretching with simulated peristalsis, or both [102], few 
have attempted to replicate the hydrostatic pressure that cells experi-
ence in vivo. As there has been shown to be a relationship between hy-
drostatic pressure and absorption by the endothelial cells [99,100], this 
may prove to be an important factor. Furthermore, due to the distinct 
crypt-villus architecture observed in vivo, idealized intestinal scaffolds 
should recapitulate this topology with surface density of 10− 40 mm2 
and height between 500− 1000 μm [140]. The newly formed crypt-villus 
apical surface of the scaffold and continuous perfusion at either apical or 
basolateral channels would permit the maintenance of a soluble-factor 
gradient, such as Notch, Noggin, BMP, Hedgehog and Ephrin, along 
the crypt-villus interface which is essential in supporting the correct 
lineage differentiation of the mucosal cell subtypes. 
Moreover, the polymer crypt-villus scaffold framework would 
require biodegradability matching the rate of new tissue formation. The 
biodegradable nature of this scaffold would allow mucosal cells to 
remodel their surroundings by replacing it with their own naturally 
deposited ECM, thus giving rise to a mature homeostatic niche. Addi-
tionally, the intestinal scaffold should recapitulate the biochemical and 
biophysical niche microenvironment of the stem cells, transient ampli-
fying and differentiated cell compartments. These parameters are 
defined by the insoluble ECM protein deposition of cellular compart-
ments and the spatial gradient of basement membrane stiffness. Both 
factors, as described previously, are spatially distinct in each of the three 
compartments’ crypt, crypt-villus junction, and villus. Indeed, both play 
an important role in healthy cell lineage development. Lastly, the un-
derlying basolateral chamber, representing the stromal compartments, 
should contain niche-specific cells in order to closely mimic the native 
tissue, including various immune cells (monocytes and lymphocytes) 
and stromal cells (fibroblasts, myofibroblasts, pericytes, endothelial 
cells) [141]. The cells found in the underlying sub-mucosal compart-
ment are believed to have an important functional role in establishing 
paracrine signaling events to regulate full lineage development and 
differentiation of the epithelium mucosa [142]. 
The complexity of intestinal tissue makes it challenging to incorpo-
rate all of the outlined features above into a single in vitro system. In the 
preceding sections, we discussed the current state of the art technology, 
ranging from traditional 2D cell monolayers to more sophisticated dy-
namic 3D models (organ-chip). Regardless of the advancements made, 
there is still much work to be done in order to address and incorporate 
the crucial design features outlined above. 
5. Conclusions and future perspectives 
Globally, many groups have addressed some of the requirements for 
the ideal intestinal in vitro model. The rapidly advancing fabrication 
technology used to manufacture sophisticated 3D scaffolds in the near 
future should allow for the manufacture of spatially unique layered 
scaffolds that would better relate to the heterogeneous biochemical and 
biophysical nature of in vivo organs. However, in order to mimic the 
spatial biochemical composition of ECM proteins from crypt to villus 
regions, an extensive biochemical and biophysical characterization at 
those regions is required. A plethora of studies have indeed acknowl-
edged the importance of matrix stiffness and the morphological effects 
they have on various stem cell lineages [143–145] and how different 
ECM proteins influence cell behavior. Thus, it is worthwhile to from an 
understanding of these biochemical and biophysical parameters along 
the crypt-villus axis when designing 3D intestine-like scaffolds. 
Indeed, as in vitro models continue to advance in their accuracy and 
sophistication, they will increase understanding of physiologically 
relevant controls of cellular behavior. This in turn will lead to greater 
fidelity in the study of organ physiology and pathophysiology. Ulti-
mately contributing to an understanding in areas of therapeutic tissue 
engineering, wound healing, or eventually, to replace diseased and 
damaged tissue. 
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Fig. 8. Idealized intestinal model. To fully mimic the native tissue, an idealized intestinal scaffold should include or consider the following; continuously apically and 
basolaterally perfused chambers, with microbiome at the apical chamber, and immune and other stromal cells at the basolateral chamber. In order to support 
microbiome development, a decreasing O2 gradient should span from the basolateral chamber to the apical. Various soluble factor gradients along the crypt villus 
axis should be established by defining concentrations in apical or basolateral media. Lastly, the 3D bioscaffold supporting the epithelial development, should be 
composed of biomechanically and biochemically unique layers with physical parameters and ECM found in native tissue at the crypt, progenitor and villus regions. 
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[6] Ö.H. Yilmaz, P. Katajisto, D.W. Lamming, Y. Gültekin, K.E. Bauer-Rowe, 
S. Sengupta, K. Birsoy, A. Dursun, V. Onur Yilmaz, M. Selig, G.P. Nielsen, 
M. Mino-Kenudson, L.R. Zukerberg, A.K. Bhan, V. Deshpande, D.M. Sabatini, 
MTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie 
intake, Nature 486 (2012) 490–495, https://doi.org/10.1038/nature11163. 
[7] M. Igarashi, L. Guarente, Cell Cycle the Unexpected Role of mTORC1 in Intestinal 
Stem Cells During Calorie Restriction, 2016, https://doi.org/10.1080/ 
15384101.2016.1221210. 
[8] C. Crosnier, D. Stamataki, J. Lewis, Organizing cell renewal in the intestine: stem 
cells, signals and combinatorial control, Nat. Rev. Genet. 7 (2006) 349–359, 
https://doi.org/10.1038/nrg1840. 
[9] Q. Tan, P.P.Y. Lui, Y.W. Lee, In vivo identity of tendon stem cells and the roles of 
stem cells in tendon healing, Stem Cells Dev. 22 (2013) 3128–3140, https://doi. 
org/10.1089/scd.2013.0073. 
[10] K.M. Braun, F.M. Watt, Epidermal label-retaining cells: background and recent 
applications, J. Investig. Dermatology Symp. Proc. (2004), https://doi.org/ 
10.1111/j.1087-0024.2004.09313.x. 
[11] E. Rangel-Huerta, E. Maldonado, Transit-amplifying cells in the fast lane from 
stem cells towards differentiation, Stem Cells Int. 2017 (2017), https://doi.org/ 
10.1155/2017/7602951. 
[12] R. Tahvonen, S. Salminen, Functional foods for gut health: an overview. Funct. 
Foods, Ageing Degener. Dis., Woodhead, 2004, pp. 295–324. 
[13] G.C. Hansson, Role of mucus layers in gut infection and inflammation, Curr. Opin. 
Microbiol. 15 (2012) 57–62, https://doi.org/10.1016/j.mib.2011.11.002. 
[14] N. Kobayashi, D. Takahashi, S. Takano, S. Kimura, K. Hase, The roles of Peyer’s 
patches and microfold cells in the gut immune system: relevance to autoimmune 
diseases, Front. Immunol. 10 (2019), https://doi.org/10.3389/ 
fimmu.2019.02345. 
[15] A.T. Mah, K.S. Yan, C.J. Kuo, Wnt pathway regulation of intestinal stem cells, 
J. Physiol. (Paris) 594 (2016) 4837–4847, https://doi.org/10.1113/JP271754. 
[16] S.M. Neerven, L. Vermeulen, Balancing signals in the intestinal niche, EMBO J. 36 
(2017) 389–391, https://doi.org/10.15252/embj.201796431. 
[17] M. Spit, B.K. Koo, M.M. Maurice, Tales from the crypt: intestinal niche signals in 
tissue renewal, plasticity and cancer, Open Biol. 8 (2018), https://doi.org/ 
10.1098/rsob.180120. 
[18] D.J. Flanagan, C.R. Austin, E. Vincan, T.J. Phesse, Wnt signalling in 
gastrointestinal epithelial stem cells, Genes (Basel). 9 (2018), https://doi.org/ 
10.3390/genes9040178. 
[19] S. Koch, Extrinsic control of Wnt signaling in the intestine, Differentiation 97 
(2017) 1–8, https://doi.org/10.1016/j.diff.2017.08.003. 
[20] M.P. Verzi, R.A. Shivdasani, Wnt signaling in gut organogenesis, Organogenesis 4 
(2008) 87–91, https://doi.org/10.4161/org.4.2.5854. 
[21] T. Fevr, S. Robine, D. Louvard, J. Huelsken, Wnt/β-catenin is essential for 
intestinal homeostasis and maintenance of intestinal stem cells, Mol. Cell. Biol. 27 
(2007) 7551–7559, https://doi.org/10.1128/mcb.01034-07. 
[22] C. Kosinski, V.S.W. Li, A.S.Y. Chan, J. Zhang, C. Ho, W. Yin Tsui, T. Leung Chan, 
R.C. Mifflin, D.W. Powell, S. Tsan Yuen, S. Yi Leung, X. Chen, Gene expression 
patterns of human colon tops and basal crypts and BMP antagonists as intestinal 
stem cell niche factors, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15418–15423, 
https://doi.org/10.1073/pnas.0707210104. 
[23] Z. Qi, Y. Li, B. Zhao, C. Xu, Y. Liu, H. Li, B. Zhang, X. Wang, X. Yang, W. Xie, B. Li, 
J.D.J. Han, Y.G. Chen, BMP restricts stemness of intestinal Lgr5 + stem cells by 
directly suppressing their signature genes, Nat. Commun. 8 (2017), https://doi. 
org/10.1038/ncomms13824. 
[24] A.-P.G. Haramis, H. Begthel, M. Van Den Born, J. Van Es, S. Jonkheer, G. Johan, 
A. Offerhaus, H. Clevers, De novo crypt formation and juvenile polyposis on BMP 
inhibition in mouse intestine, Science (80-.) 303 (2004) 1684–1686, https://doi. 
org/10.1126/science.1093587. 
[25] A. García de Vinuesa, S. Abdelilah-Seyfried, P. Knaus, A. Zwijsen, S. Bailly, BMP 
signaling in vascular biology and dysfunction, Cytokine Growth Factor Rev. 27 
(2016) 65–79, https://doi.org/10.1016/j.cytogfr.2015.12.005. 
[26] L.E. Batts, D. Brent Polk, R.N. Dubois, H. Kulessa, B. Hogan, Bmp signaling is 
required for intestinal growth and morphogenesis, Dev. Dyn. 235 (2006) 
1563–1570, https://doi.org/10.1002/dvdy.20741. 
[27] C. Cortina, S. Palomo-Ponce, M. Iglesias, J.L. Fernández-Masip, A. Vivancos, 
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Myotubes differentiate optimally on substrates with tissue-like stiffness: 
pathological implications for soft or stiff microenvironments, J. Cell Biol. 166 
(2004) 877–887, https://doi.org/10.1083/jcb.200405004. 
[145] A.J. García, C.D. Reyes, Bio-adhesive surfaces to promote osteoblast 
differentiation and bone formation, J. Dent. Res. 84 (2005) 407–413, https://doi. 
org/10.1177/154405910508400502.  
S. Malijauskaite et al.                                                                                                                                                                                                                          
Cytokine and Growth Factor Reviews 60 (2021) 76–88
88
Sigita Malijauskaite completed her Bachelor of Science in 
industrial biochemistry in the University of Limerick, Ireland. 
Excellent academic achievements and several competitive 
research placements awarded to her during her undergraduate 
has led to an Irish Research Council (IRC) funded postgraduate 
scholarship, allowing her to undertake her PhD training in Dr. 
Kieran McGourty’s lab. Sigita’s PhD project focuses on intes-
tinal tissue. Specifically, on the biochemical and biophysical 
cues arising from the cells’ microenvironment that drive 
quiescence, proliferation and terminal differentiation.  
Sinead Connolly received a first class Bachelor of Engineering 
in biomedical engineering from the University of Limerick, 
Ireland. She currently holds a position as a PhD candidate in the 
School of Engineering and Bernal Institute at the University of 
Limerick. Her main research focus is in biomicrofluidics, 
particularly in relation to the advection of cells in Poiseuille 
microflows.  
Dr. David Newport is a senior lecturer at the School of Engi-
neering and Bernal Institute at the University of Limerick, 
Ireland. He obtained a first Class Bachelor of Engineering in 
mechanical engineering in 1996, and a PhD in thermo-fluid 
mechanics, awarded in 2000 from the University of Limerick. 
He joined the faculty at the School of Engineering in 2004. Dr 
Newport currently leads a team of 5 PhD researchers in 
biomedical fluid mechanics, having graduated 13 PhD students 
and mentored 13 postdoctoral researchers to date. He has 
published over 50 peer reviewed journal papers, being cited 
over 430 times (h-index 10), and secured in excess of €4 M from 
industrial, national and EU funding sources. Dr Newport’s 
research is focussed on Process and Biomedical applications for microfluidics, with an 
emphasis on experimental methods. He has a long-standing interest in the development of 
optical metrology techniques for microfluidic flows, in particular interferometry. A key 
research theme is the microfluidic context experienced by cells in in-vivo and in-vitro 
environments, such as the advection and viability of cell suspensions in microflows, se-
lection of sperm for assisted reproduction, and in-vitro models of the blood-brain-barrier. 
He is also engaged in the detection of volatile organic compounds (VOCs) in air using 
miniaturized sensors. Dr Newport is a co-chair of the European Conference on 
Microfluidics.  
Dr. Kieran McGourty is currently a lecturer in the Chemical 
Sciences department at the University of Limerick, Ireland. He 
obtained a Bachelor of Science in industrial biochemistry in the 
University of Limerick, where he worked with Dr. Jakki Coo-
ney and Dr. Todd Kagawa. In 2006, motivated by these expe-
riences, he went on to attain a Wellcome Trust funded PhD, 
working with Prof. David Holden FRS, Imperial College London 
to study the molecular basis of infection. During this time, Dr 
McGourty published several high impact papers on the intra-
cellular interaction of Salmonella Typhimurium with the host 
before changing field from cellular microbiology to cell 
biology. He took a post-doctoral research position in 2012 with 
Dr. Emmanuel Boucrot at University College London (UCL), with a primary research focus 
on the cell cycle and extracellular matrix (ECM) biology. His work here resulted in an 
extensive study into how ECM interaction evoke specific intracellular signalling profiles in 
quiescent cells. Kieran’s research at UL continued investigation into cell regulation and 
aims to understand the signals that govern cell behaviour, especially the intestinal, 
muscular and epidermal niche. He employs a number of high-throughput techniques to 
achieve this including; transcriptomics, single cell multiomics, phosphoproteomics and 
high content imaging, in addition to standard biochemical techniques. Lastly, Kieran is a 
committee member of Matrix Biology Ireland and is a Local Ambassador for the 
Biochemical Society. 
S. Malijauskaite et al.                                                                                                                                                                                                                          
